Common TitleSURVEYOR-I and SURVEYOR-II
Official Title Glecaprevir and Pibrentasvir Yield High Response Rates in Patients with HCV Genotype 1-6 without Cirrhosis.
Phase Phase II
ClinicalTrials.gov NCT02243280
Treatments
Glecaprevir-Pibrentasvir

Glecaprevir-Pibrentasvir
Tradename:MavyretOther Names:GLE-PIBClass:FDA-ApprovedFunding
IndustryAbbVie